MiniMed Group, Inc. MMED 深 滬
等待開盤 06-25 09:30:00 美东时间
14.13
+0.390
+2.84%
華盛通- 最 高14.98
- 今 開13.97
- 成交量 111.17万股
- 最 低 13.95
- 昨 收 13.74
- 總市值 39.68亿
- 52周最高 20.4823
- 市盈率 靜 --
- 換手率 0.40%
- 52周最低 10.65
- 委 比 -87.07%
- 總股本 2.81亿
- 歷史最高 20.4823
- 量 比 1.10
- 振 幅 7.50%
- 歷史最低 10.65
- 每 手 1
- 風險率 2.12%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股周涨跌榜 | 维多利亚的秘密周涨超35%！财报及业绩指引均超预期；获黄仁勋“喊单”，迈威尔科技周涨超28%
维多利亚的秘密周涨超35%！财报及业绩指引均超预期；迈威尔科技周涨超28%，此前获黄仁勋“喊单”！称其有望晋级万亿美元市值；传奇生物周涨超20%，CAR-T细胞疗法实验数据引爆市场>>
06-06 11:25
美股大行评级 | 绩后暴跌，博通仍获11家大行上调目标价；CrowdStrike获21家大行集体上调目标价；Netskope、Veeva Systems惨遭多家大行下调目标价
今日重点评级关注：Ascendiant Capital：维持Vivos Therapeutics"买入"评级，目标价从3美元升至3.1美元；富国银行：维持Veeva Systems"超配"评级，目标价从317美元升至320美元
06-05 11:33
美股牛股 | 黄仁勋概念股又+1！凭AI电源技术切入“达链”，纳微半导体暴涨超19%；MiniMed Group大涨近16%
黄仁勋概念股又+1！凭AI电源技术切入“达链”，纳微半导体暴涨超19%；季度销售额超预期！MiniMed Group大涨近16%>>
06-04 18:56
Full Transcript: Minimed Group Q4 2026 Earnings Call
Minimed Group (NASDAQ:MMED) held its fourth-quarter earnings conference call on...
06-03 21:49
Earnings Scheduled For June 3, 2026
Companies Reporting Before The Bell • VersaBank (NASDAQ:VBNK) is expected to re...
06-03 19:11
Minimed Group Q4 EPS $(0.68) Misses $0.11 Estimate, Sales $837.000M Beat $789.096M Estimate
Minimed Group (NASDAQ:MMED) reported quarterly losses of $(0.68) per share which missed the analyst consensus estimate of $0.11 by 718.18 percent. This is unchanged from the same period last year. The company reported
06-03 18:59
MiniMed Announces Expanded Agreement With Abbott To Collaborate On Commercializing Dual Glucose-Ketone Sensors Designed To Integrate Exclusively With MiniMed Smart Dosing Systems
Agreement builds on the companies' ongoing partnership to expand choice and simplify diabetes managementNORTHRIDGE, Calif., June 3, 2026 /CNW/ -- MiniMed (NASDAQ:MMED), a global leader in diabetes technology, today
06-03 18:50
美股大行评级 | 花旗上调英特尔目标价至130美元；大摩上调英伟达目标价至285美元；National 、Yesway获多家大行首予买入评级
今日重点评级关注：TD Cowen：维持Strive"买入"评级，目标价从28美元升至30美元；蒙特利尔银行：维持KinderCare Learning"跑赢大市"评级，目标价从4美元升至6美元
05-19 10:55
美股大行评级 | 富国银行上调英伟达目标价从265美元升至315美元；Alamar、AEVEX获多家大行首予“买入”评级
今日重点评级关注：Needham：维持Artiva Biotherapeutics"买入"评级，目标价从18美元升至41美元；HC Wainwright & Co.：维持SAB Biotherapeutics"买入"评级，目标价从7美元升至10美元
05-13 11:46
Benchmark Initiates Coverage On Minimed Group with Buy Rating, Announces Price Target of $20
Benchmark analyst Bruce Jackson initiates coverage on Minimed Group (NASDAQ:MMED) with a Buy rating and announces Price Target of $20.
05-12 19:59
